Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle
- 9 April 2002
- Vol. 20 (21-22) , 2693-2701
- https://doi.org/10.1016/s0264-410x(02)00203-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.Proceedings of the National Academy of Sciences, 1996
- The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and PasteurEpidemiology and Infection, 1996
- Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoproteinJournal of General Virology, 1994
- Recombinant poxvirus vaccinesReviews in Medical Microbiology, 1993
- Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheepArchiv für die gesamte Virusforschung, 1993
- Immunisation with canarypox virus expressing rabies glycoproteinThe Lancet, 1992
- Potential use of non-replicating vectors as recombinant vaccinesVaccine, 1992
- Efficacy studies on a canarypox-rabies recombinant virusVaccine, 1991
- Expression of rabies virus glycoprotein from a recombinant vaccinia virusNature, 1984
- Structure of the glycoprotein gene in rabies virusNature, 1981